96 related articles for article (PubMed ID: 27269920)
1. [Correlation between cyclin-dependent kinase inhibitor p27kip1 and trastuzumab-resistance in gastric cancer].
Wu M; Guo L; Zuo Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 May; 41(5):471-6. PubMed ID: 27269920
[TBL] [Abstract][Full Text] [Related]
2. Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance.
Zuo Q; Liu J; Zhang J; Wu M; Guo L; Liao W
Sci Rep; 2015 Jun; 5():11634. PubMed ID: 26108989
[TBL] [Abstract][Full Text] [Related]
3. An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.
Piro G; Carbone C; Cataldo I; Di Nicolantonio F; Giacopuzzi S; Aprile G; Simionato F; Boschi F; Zanotto M; Mina MM; Santoro R; Merz V; Sbarbati A; de Manzoni G; Scarpa A; Tortora G; Melisi D
Clin Cancer Res; 2016 Dec; 22(24):6164-6175. PubMed ID: 27267856
[TBL] [Abstract][Full Text] [Related]
4. miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
Zhou X; Men X; Zhao R; Han J; Fan Z; Wang Y; Lv Y; Zuo J; Zhao L; Sang M; Liu XD; Shan B
Cancer Gene Ther; 2018 May; 25(3-4):68-76. PubMed ID: 29302045
[TBL] [Abstract][Full Text] [Related]
5. Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
Zhu Y; Tian T; Zou J; Wang Q; Li Z; Li Y; Liu X; Dong B; Li N; Gao J; Shen L
BMC Cancer; 2015 Nov; 15():894. PubMed ID: 26560145
[TBL] [Abstract][Full Text] [Related]
6. [Effect of weikangning decoction on expression of cyclin E, CDK2, and p27].
Kan FJ; Li QM; Zhong W; Liang WW
Zhong Yao Cai; 2006 Apr; 29(4):341-5. PubMed ID: 16913488
[TBL] [Abstract][Full Text] [Related]
7. MMP7 Induces T-DM1 Resistance and Leads to the Poor Prognosis of Gastric Adenocarcinoma
Li H; Xu X; Liu Y; Li S; Zhang D; Meng X; Lu L; Li Y
Anticancer Agents Med Chem; 2018; 18(14):2010-2016. PubMed ID: 30501604
[TBL] [Abstract][Full Text] [Related]
8. CacyBP/SIP nuclear translocation regulates p27Kip1 stability in gastric cancer cells.
Niu YL; Li YJ; Wang JB; Lu YY; Liu ZX; Feng SS; Hu JG; Zhai HH
World J Gastroenterol; 2016 Apr; 22(15):3992-4001. PubMed ID: 27099442
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells.
Marches R; Uhr JW
Int J Cancer; 2004 Nov; 112(3):492-501. PubMed ID: 15382077
[TBL] [Abstract][Full Text] [Related]
10. P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells.
Wei M; Wang Z; Yao H; Yang Z; Zhang Q; Liu B; Yu Y; Su L; Zhu Z; Gu Q
BMC Cancer; 2011 Mar; 11():109. PubMed ID: 21439087
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.
Arienti C; Zanoni M; Pignatta S; Del Rio A; Carloni S; Tebaldi M; Tedaldi G; Tesei A
Oncotarget; 2016 Apr; 7(14):18424-39. PubMed ID: 26919099
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance.
Liu W; Chang J; Liu M; Yuan J; Zhang J; Qin J; Xia X; Wang Y
Oncotarget; 2017 Jul; 8(28):45793-45806. PubMed ID: 28507275
[TBL] [Abstract][Full Text] [Related]
13. P27(kip1) down-regulation is associated with trastuzumab resistance in breast cancer cells.
Nahta R; Takahashi T; Ueno NT; Hung MC; Esteva FJ
Cancer Res; 2004 Jun; 64(11):3981-6. PubMed ID: 15173011
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop.
Yang Z; Guo L; Liu D; Sun L; Chen H; Deng Q; Liu Y; Yu M; Ma Y; Guo N; Shi M
Oncotarget; 2015 Mar; 6(7):5072-87. PubMed ID: 25669984
[TBL] [Abstract][Full Text] [Related]
15. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells.
Kim JH; Kim HP; Jung CH; Hong MH; Hong MC; Bae HS; Lee SD; Park SY; Park JH; Ko SG
Int J Mol Med; 2006 Jul; 18(1):201-8. PubMed ID: 16786174
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.
Gong SJ; Jin CJ; Rha SY; Chung HC
Cancer Lett; 2004 Oct; 214(2):215-24. PubMed ID: 15363548
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model.
Yamashita-Kashima Y; Shu S; Harada N; Fujimoto-Ouchi K
Oncol Rep; 2013 Sep; 30(3):1087-93. PubMed ID: 23783223
[TBL] [Abstract][Full Text] [Related]
19. Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line.
Chen W; Wei F; Xu J; Wang Y; Chen L; Wang J; Guan X
Int J Mol Med; 2011 Dec; 28(6):985-91. PubMed ID: 21887460
[TBL] [Abstract][Full Text] [Related]
20. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor.
Tseng PH; Wang YC; Weng SC; Weng JR; Chen CS; Brueggemeier RW; Shapiro CL; Chen CY; Dunn SE; Pollak M; Chen CS
Mol Pharmacol; 2006 Nov; 70(5):1534-41. PubMed ID: 16887935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
